Ropeginterferon alfa-2b in Polycythemia Vera: A systematic review and meta-analysis. | ClinicLens
Ropeginterferon alfa-2b, a novel monopegylated interferon with improved pharmacokinetics, has emerged as a promising cytoreductive agent for managing polycythemia vera (PV). Despite increasing adoption, evidence synthesis of its efficacy and safety compared to standard care remai
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.